Dr. Professor John Gribben

About Dr. Professor John Gribben

Professor John Gribben graduated from the University of Glasgow in 1980.
He trained in Haematology at University College London and in Medical Oncology at the Dana-Farber Cancer Institute, Harvard Medical School.
He remained on the faculty at Harvard Medical School for 17 years before returning to the UK.
He specialises in haematological cancers including lymphomas, leukaemias, and bone marrow transplantation.
His NHS post is as Consultant Haematologist and Medical Oncologist at Barts and The London NHS Trust.
He has authored more than 300 articles and chapters in peer-reviewed publications.
He has an international reputation for pioneering research into new drugs and forms of cancer treatment.
His studies in leukaemia and lymphoma have been supported by grant funding from The National Cancer Institute and Cancer Research UK.
He has chaired and served on numerous international executive committees dedicated to improving cancer care.
He is a member of the editorial boards of several professional publications focused on cancer.
He has delivered lectures worldwide on new therapies for cancer treatment.

Conditions treated by Dr. Professor John Gribben

Lymphomas (including Hodgkin’s and Non-Hodgkin’s lymphoma)
Leukaemias (acute and chronic forms, including CLL and AML)
Myeloma (multiple myeloma and related plasma cell disorders)
Bone marrow failure syndromes
Blood cancers requiring bone marrow transplantation
Complications of chemotherapy and targeted therapies
Relapsed and refractory haematological cancers

Area of Interest

Haematology and Oncology

Qualification

Medical Degree (MBChB/MD), University of Glasgow, 1980
Specialist Training in Haematology, University College London
Specialist Training in Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School

Work Experiences

Faculty member at Harvard Medical School for 17 years, conducting research and teaching in haematology and oncology.
Consultant Haematologist and Medical Oncologist at Barts and The London NHS Trust, UK.

Global Team of Board Certified Surgeons and Medical Specialists
Written Second Opinion report delivered within 5 days
Option to avail the Video Consultation with the Lead Doctor of the board

Access Our most trusted Medical Second Opinion

Telemedicine Doctors

Do you know?

You can book a video consultation with Dr. Professor John Gribben on our platform

Consult Online

CERTIFICATIONS (1)

Fellow of the Royal College of Physicians (FRCP), UK

MEMBERSHIPS (4)

Member of European Hematology Association (EHA)
Member of American Society of Hematology (ASH)
Member of British Society for Haematology (BSH)
Editorial board member for multiple cancer-focused journals

RESEARCH PAPERS AND PUBLICATIONS (4)

Middle East Medical Portal: Explains why CAR T-cell therapy has the potential to revolutionise cancer treatment.
Marylebone Journal: Consultant haematologist at The London Clinic discusses CAR T-cell therapy and its transformative potential.
Daily Mail: Quoted on how a 53-year-old NHS patient became one of the first to benefit from pioneering immunotherapy.
Marylebone Journal: Interview discussing stem cells, research, and the immune system.

Share Your Experience about Dr. Professor John Gribben

Write Your Review

PROCEDURES

Bone Marrow Transplant

FREQUENTLY ASKED QUESTIONS

Is Dr. Professor John Gribben doing teleconsultation on the MediGence platform?

Dr. Professor John Gribben is available to teleconsult on the MediGence platform.

How long is the consultation?

The consultation can last from 15 to 30 minutes. It may exceed the estimated time, depending on the patient’s queries and the doctor's medical suggestions.

How soon can the consultation be organised?

We have Medical specialists and board-certified doctors on our panel of doctors. The consultation will be organised within 24 to 48 hours or based on the availability of the doctor and the patient.

Is a follow-up consultation included in the consultation price?

No, the follow-up consultation fee is not included in the consultation price. The patient will be required to re-book the consultation.

How do I share my medical record with the doctor for review?

The option to share your medical records is available between the steps of the form provided to you on the website.

Can I book my procedure with the doctor post-consultation?

Yes. If you are satisfied with the consultation, you can go ahead with treatment packages for your diagnosis with the help of our case managers.

Can you get an estimate for the procedure?

Yes. The cost estimate will be provided to you by our case manager, including the doctor’s opinion, the cost estimate, and crucial information about traveling to your medical destination.

FAQ's Related to Hematologist

What does a Hemato-oncologist do?

A hemato-oncologist specialises in diagnosing and treating blood disorders and cancers, including leukaemias, lymphomas, myeloma, and other blood-related conditions.

When should I see a Hemato-oncologist?

You should consult a hemato-oncologist if you have abnormal blood counts, unexplained bruising or bleeding, persistent fatigue, swollen lymph nodes, or a diagnosis of blood cancer.

How are blood cancers diagnosed?

Diagnosis may involve blood tests, bone marrow biopsy, imaging scans, and genetic or molecular testing to determine the type and stage of the disease.

What treatments do hemato-oncologists provide?

They provide chemotherapy, targeted therapy, immunotherapy, CAR T-cell therapy, bone marrow/stem cell transplantation, and supportive care to manage symptoms and complications.

What is CAR T-cell therapy?

CAR T-cell therapy is an advanced immunotherapy that modifies a patient’s T-cells to target and kill cancer cells, used mainly for certain types of leukaemia and lymphoma.

How often will I need to see a haematologist during treatment?

Follow-up frequency depends on your diagnosis and treatment plan, ranging from weekly during intensive therapy to monthly or quarterly for monitoring remission.

Can haematologist-oncologists treat both adults and children?

Some specialists focus on adult patients, while paediatric haematologists manage blood disorders in children.

Is a second opinion recommended?

Yes, getting a second opinion is common, especially for complex or rare blood cancers, to explore all treatment options.

Can blood cancers be cured?

Many blood cancers can be treated successfully, with some achieving long-term remission or cure depending on type, stage, and treatment response.

Welcome To MediGence

Your Notifications